-
DE
T-regulatory cells (Tregs) are specialized immune cells that suppress excessive immune responses and play a key role in preventing autoimmune diseases.
T-regulatory cells (Tregs) are specialized immune cells that suppress excessive immune responses and play a key role in preventing autoimmune diseases.
T-regulatory cells (Tregs) are a specialized subset of T-lymphocytes, a type of white blood cell that is part of the immune system. Their primary role is to control and limit immune responses, preventing overactive or misdirected reactions. They are central to maintaining immunological tolerance, which means helping the immune system learn not to attack the body's own tissues.
Tregs are mainly produced in the thymus (known as natural Tregs or tTregs) but can also develop from conventional T cells in peripheral tissues (induced Tregs or pTregs). A key identifying feature is the transcription factor FoxP3, which is considered the master regulator of Treg development and function.
The main mechanisms by which T-regulatory cells work include:
In many autoimmune diseases such as type 1 diabetes, multiple sclerosis, rheumatoid arthritis, or systemic lupus erythematosus, the number or function of Tregs is reduced. This allows the immune system to attack the body's own tissues. Research is focused on therapeutically strengthening Tregs to treat these conditions.
Tregs also play an important role in allergic diseases. Impaired Treg function can lead to excessive allergic reactions, for example to pollen or food. Allergen immunotherapy (desensitization) works in part through the induction of regulatory T cells.
In tumor immunology, Tregs have a dual role. On one hand, they can prevent the immune system from recognizing and attacking tumor cells, thus promoting tumor growth. On the other hand, they protect healthy tissue from excessive inflammatory reactions. Modern immune checkpoint therapies for cancer aim in part to overcome the suppressive effect of Tregs within the tumor microenvironment.
After organ transplantation, sufficient Treg activity is desirable because it helps prevent the rejection of the donor organ. Clinical studies are investigating the use of Treg-based therapies to reduce the need for immunosuppressive drugs.
During pregnancy, Tregs are essential for allowing the maternal immune system to tolerate the genetically semi-foreign fetus without triggering a rejection response.
Tregs can be identified in the laboratory using flow cytometry (FACS) based on specific surface markers. Typical markers are CD4+CD25+FoxP3+. The analysis of Treg numbers and function is part of scientific research into autoimmune diseases, tumor biology, and transplantation medicine. Therapeutic approaches targeting Tregs are currently being explored in clinical trials.
For Healthy Oral Flora & Dental Care
Formulated lozenges with Dentalac®, lactic acid bacteria, and Lactoferrin CLN®
For Healthy Oral Flora & Dental Care
Formulated lozenges with Dentalac®, lactic acid bacteria, and Lactoferrin CLN®
For your universal protection
As one of the most valuable proteins in the body, lactoferrin is a natural component of the immune system.
For your iron balance
Specially formulated for your iron balance with plant-based curry leaf iron, Lactoferrin CLN®, and natural Vitamin C from rose hips.